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ABSTRACT
TheCXCL12/CXCR4 signaling pathway is involved in the development
of numerous neuronal and non-neuronal structures. Recent work
established that the atypical second CXCL12 receptor, CXCR7, is
essential for the proper migration of interneuron precursors in the
developing cerebral cortex. Two CXCR7-mediated functions were
proposed in this process: direct modulation of β-arrestin-mediated
signaling cascades and CXCL12 scavenging to regulate local
chemokine availability and ensure responsiveness of the CXCL12/
CXCR4 pathway in interneurons. Neither of these functions has been
proven in the embryonic brain. Here, we demonstrate that migrating
interneurons efficiently sequester CXCL12 through CXCR7. CXCR7
ablation causes excessive phosphorylation and downregulation of
CXCR4 throughout the cortex in mice expressing CXCL12, but not
in CXCL12-deficient animals. Cxcl12−/− mice lack activated CXCR4 in
embryonic brain lysates and display a similar interneuron positioning
defect as Cxcr4−/−, Cxcr7−/− and Cxcl12−/−;Cxcr7−/− animals. Thus,
CXCL12 is theonlyCXCR4-activating ligand in the embryonic brain and
deletion of one of the CXCL12 receptors is sufficient to generate a
migration phenotype that corresponds to the CXCL12-deficient
pathway. Our findings imply that interfering with the CXCL12-
scavenging activity of CXCR7 causes loss of CXCR4 function as a
consequence of excessive CXCL12-mediated CXCR4 activation and
degradation.
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INTRODUCTION
The chemokine CXCL12 regulates cell migration and homing
processes in the immune system, hematopoietic system, brain,
and other tissues (Stumm and Hollt, 2007; Miller et al., 2008;
Tiveron and Cremer, 2008; Lewellis and Knaut, 2012). It mediates
its effects through canonical G protein-coupled CXCR4 and
through CXCR7 (Bleul et al., 1996; Oberlin et al., 1996;
Balabanian et al., 2005; Burns et al., 2006). The latter is also
referred to as atypical chemokine receptor 3 (ACKR3) because it
does not signal through G proteins and elicits no chemotaxis
(Thelen and Thelen, 2008). Instead, CXCR7 sequesters CXCL12
from the extracellular environment and, thus, functions as a
CXCL12 scavenger (Venkiteswaran et al., 2013; Boldajipour et al.,
2008; Luker et al., 2010; Naumann et al., 2010; Hoffmann et al.,
2012). Like other heptahelical receptors, including CXCR4,
CXCR7 is also capable of modulating downstream pathways
through β-arrestin (Cheng et al., 2000; Kalatskaya et al., 2009;
Rajagopal et al., 2010). Thus, CXCL12 signaling is subject to
particularly complicated regulation. Unraveling the underlying
mechanisms will facilitate an understanding of CXCL12-mediated
cell guidance and the development of new treatment strategies for
cell migration disorders.
Defective CXCR4 regulation has recently been implicated in the
perturbed intracortical migration of GABAergic interneurons in
genetic schizophrenia models (Meechan et al., 2012; Toritsuka
et al., 2013). Cortical interneurons originate in the ganglionic
eminences in the ventral telencephalon (Anderson et al., 1997;
Marín and Rubenstein, 2001; Hernández-Miranda et al., 2010).
They seek the cortical marginal zone (MZ) and subventricular/
intermediate zone (SVZ/IZ), where their migration depends on
CXCL12 emanating from meningeal cells and pyramidal cell
progenitors (Tiveron et al., 2006; Tanaka et al., 2009; Sessa et al.,
2010; Zarbalis et al., 2012). Most interneurons express both
CXCL12 receptors, and interneurons deficient for CXCR4 or
CXCR7 display opposite motility defects (Wang et al., 2011). This
suggests that distinct CXCR4-dependent and CXCR7-dependent
pathways might exist in interneurons: CXCR4 attracts cells towards
CXCL12 through a G protein-dependent pathway (Lysko et al.,
2011), whereas CXCR7 modulates MAP kinases through β-arrestin
(Wang et al., 2011).
Having observed that CXCR7-deficient interneurons display
severely reduced CXCR4 levels and loss of CXCR4 function
(Sánchez-Alcañiz et al., 2011), we proposed that CXCR7 regulates
interneuron migration by preserving CXCR4. This is consistent
with the observation that a reduction in CXCR4 disrupts CXCL12-
mediated interneuron guidance (Meechan et al., 2012). Given that
proper CXCR4 regulation is essential in interneurons, we examined
how the two receptors cooperate in this system. We first tested
whether the similar interneuron positioning defects in Cxcr4−/−
and Cxcr7−/− mutants (Sánchez-Alcañiz et al., 2011; Wang et al.,
2011) reflect a fully CXCL12-defective pathway by assessing
interneuron layering in Cxcr4−/−, Cxcr7−/− and Cxcl12−/− mice.
This showed that inactivation of one of the CXCL12 receptors
is sufficient to generate the phenotype observed in mice
lacking CXCL12 signaling. We then demonstrated that migrating
interneurons sequester CXCL12 through CXCR7, which supports
the concept that CXCR7 acts as a CXCL12 scavenger in these cells.
Finally, we conducted biochemical and histochemical studies, from
which we conclude that loss of CXCR7 leads to excessive
CXCL12-mediated activation and downregulation of CXCR4 in
interneurons.Received 11 October 2013; Accepted 12 March 2014
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RESULTS AND DISCUSSION
Cxcl12−/−, Cxcr4−/− and Cxcr7−/−mice display similar
interneuron layering defects
To examine whether aberrant interneuron layering in Cxcr4−/− and
Cxcr7−/− mutants corresponds to a partial or complete CXCL12
signaling defect, we examined patterns of Lhx6 (a marker for MGE-
derived interneurons), Cxcr4 and Cxcr7 expression in the cortex of
E14.5 Cxcl12−/−, Cxcr4−/− and Cxcr7−/−mouse embryos by in situ
hybridization (Fig. 1). Cell counting showed that the numbers of
Lhx6+ and Cxcr4+/Neo+ cells were reduced in the MZ and SVZ and
increased in the lower cortical plate/subplate (CP/SP) in the three
knockout lines compared with control littermates (Fig. 1Ae-g,Ce-g).
Cxcr7+ cells, as counted in Cxcl12−/−, Cxcr4−/− and control
littermates (Fig. 1Be,f ), exhibited similar abnormal distributions to
Lhx6+ cells and Cxcr4+/Neo+ cells in these knockouts. The
matching patterns of Lhx6, Cxcr4 and Cxcr7 were expected
because Lhx6+ cells constitute the main Cxcr4- and Cxcr7-
expressing population in the embryonic cortex (Sánchez-Alcañiz
et al., 2011; Wang et al., 2011). We then compared the laminar
distribution of Lhx6+ cells in Cxcl12−/−, Cxcr4−/− and Cxcr7−/−
mice using ANOVA. This revealed no significant differences,
suggesting that deletion of one of the CXCL12 receptors is
Fig. 1. Similar interneuron distribution defects in E14.5 Cxcl12−/−, Cxcr4−/− and Cxcr7−/− mice. Dark-field photographs show the dorsal telencephalon
in in situ hybridization preparations with 35S-labeled probes for Lhx6 (Aa-d), Cxcr7 (Ba-d) and Cxcr4/Neo (Ca-d) in control (Ctrl), Cxcl12−/− (XL12−/−),
Cxcr4−/− (X4−/−) and Cxcr7−/− (X7−/−) mice. The Neo probe detects Cxcr4 gene-derived transcripts in Cxcr4−/− mice (Cc). Cxcr7 transcripts are not detected
in Cxcr7−/− mutants (Bd). (Ae-g,Be,f,Ce-g) Labeled cells were counted in ten cortical bins (see counting scheme). Proportions per bin (percentage of all
counted cells) are presented as mean+s.e.m. Mutants and control littermates were compared using two-way ANOVA and Bonferroni’s post-test. *P≤0.05,
**P≤0.01 and ***P≤0.001. latV, lateral ventricle; GE, ganglionic eminence; MZ, marginal zone. Scale bar: 500 µm in Bd for Aa-d, Ba-d, Ca-d.
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sufficient to generate the interneuron layering defect observed in
animals lacking CXCL12.
In the cortex, reelin (Reln)+ Cajal-Retzius cells represent a
second major Cxcr4-expressing population that depends on
CXCL12/CXCR4 signaling (Stumm et al., 2003; Borrell and
Marín, 2006; Paredes et al., 2006). Cell counting in the parietal
cortex revealed a reduction of these cells in theMZ (supplementary
material Fig. S1A), but only a few ectopic cells in deep cortical
layers in Cxcl12−/−, Cxcr4−/− and Cxcr7−/− mice. This finding is
consistent with the reported function of CXCL12 and CXCR4 in
Cajal-Retzius cell dispersion in the MZ (Borrell and Marín, 2006).
Given that cortical Reln+ cells rarely express Cxcr7 (Schönemeier
et al., 2008), our data point to the possibility that CXCR7 exerts
some non-autonomous influence on this process.
CXCR7 sequesters CXCL12 in migrating interneurons
By examining red fluorescent protein (RFP) immunoreactivity in
the cortex of E14.5 mice expressing CXCL12-RFP fusion protein
under the Cxcl12 promoter (Jung et al., 2009), we identified
strongly stained punctae in all cortical layers. The highest densities
were observed in the MZ, SP and SVZ/IZ (Fig. 2Aa,B;
supplementary material Fig. S1D). This pattern differs markedly
from that of Cxcl12 expression, which is restricted to the meninges
and SVZ at E14.5 (Tiveron et al., 2006). Since Rfp transcripts in the
cortex of CXCL12-RFP embryos faithfully recapitulate the Cxcl12
mRNA pattern in wild types (supplementary material Fig. S1B),
we reasoned that the observed CXCL12-RFP+ punctae reflect
endocytosed and not nascent CXCL12-RFP. We therefore
quantified the number of RFP+ punctae (of size >0.5 µm2) in the
cortex of CXCL12-RFP mice lacking the CXCL12 scavenger
CXCR7 (Fig. 2Ab). Automated counting using ImageJ revealed a
74.2±9.0% reduction in Cxcr7−/−;CXCL12-RFP mice as compared
with CXCL12-RFP controls (n=4; P<0.01, Student’s t-test). Such
signal reduction was not observed after Cxcr4 deletion (Fig. 2Ac).
This indicates that most of the strong punctate RFP signal in
CXCL12-RFP mice was due to CXCR7-mediated accumulation
of CXCL12-RFP. The meninges, in which Cxcl12 is highly
expressed, exhibited similar RFP labeling in receptor-deficient
and control mice (supplementary material Fig. S1Ca-c), suggesting
that RFP signal in this tissue reflects locally expressed CXCL12-
RFP. The specificity of RFP immunostaining was controlled in
CXCL12-RFP non-transgenicCxcr7-GFP embryos (supplementary
material Fig. S1E).
Closer examination of the RFP pattern in Cxcr4−/−;CXCL12-RFP
sections revealed a signal shift towards the lower CP/SP area
(supplementary material Fig. S1D). This aberrant pattern is
reminiscent of the interneuron layering defect in Cxcr4−/− embryos,
suggesting that RFP signal was contained within interneurons. As
cortical interneurons do not express Cxcl12 (Tiveron et al., 2006;
Wang et al., 2011), we hypothesized that they sequester CXCL12-
RFP. To test this, we generated double-transgenic mice (Cxcr7-GFP;
CXCL12-RFP) and performed simultaneous live cell imaging ofGFP
and RFP in E14.5 cortical slices (Fig. 2B; supplementary material
Movie 1). Analysis of the confocal images revealed that 96% of
Cxcr7-GFP+ interneurons containedRFP+punctae. To assesswhether
CXCR7 mediates CXCL12-RFP accumulation in interneurons, we
immunostained for RFP in E14.5 Cxcr7−/−;CXCL12-RFP;Cxcr7-
GFP and CXCR7-expressing CXCL12-RFP;Cxcr7-GFP embryos
(Fig. 2Ca-d), and quantifiedGFP/RFPoverlap in the cortex (Mander’s
coefficient) using ImageJ. In the latter group, 60.3±7.1% of total RFP
was present in Cxcr7-GFP+ interneurons (Fig. 2Ca,b). In the absence
of CXCR7, the RFP signal that was contained in Cxcr7-GFP+
Fig. 2. CXCR7 accumulates CXCL12-RFP in interneurons. Confocal images show RFP in the cortex of E14.5 CXCL12-RFP transgenic mice (XL12-RFP;
false colors for RFP are indicated). (A) Immunostained RFP and DAPI in control (Aa), XL12-RFP;Cxcr7−/− (X7−/−, Ab) and XL12-RFP;Cxcr4−/− (X4−/−, Ac)
mice. (B-B00) Native RFP (B) and overlay of native GFP/RFP (B0) in a slice from a Cxcr7-GFP;XL12-RFP embryo (X7-GFP;XL12-RFP). (B00) Magnification of
the boxed area in B0 demonstrates RFP+ punctae in live GFP+ cells. These cells show migration modes characteristic of interneurons (supplementary
material Movie 1). (Ca-d) Immunostained RFP in X7-GFP;XL12-RFP (Ca,b) and X7-GFP;XL12-RFP;Cxcr7−/− (Cc,d) mice. Higher magnification images
show RFP/DAPI (Cb,d) and RFP/GFP overlays (Cb0,d0). Arrows indicate internalized CXCL12-RFP inCxcr7-GFP+ interneurons. MZ, marginal zone; CP, cortical
plate; SP, subplate; IZ/SVZ, intermediate/subventricular zone. Scale bars: 20 µm.
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interneurons was decreased by 79.9±7.2% (P<0.0001, Student’s
t-test; n=4; Fig. 2Cc,d).
We then examined whetherCxcr7-GFP+ interneurons are capable
of internalizing exogenous fluorophore-coupled CXCL12 (CXCL12-
565).After validating receptor/CXCL12-565 interaction in transfected
HEK293 cells (supplementary material Fig. S2A), we incubated
telencephalic slices from E14.5 Cxcr7-GFP mice for 30 min with
CXCL12-565. CXCL12, the CXCR4 antagonist AMD3100 and the
CXCR7 antagonist CCX771 (Zabel et al., 2009) were co-incubated in
adjacent slices. Confocal imaging of native fluorescence revealed
bright intracellular clusters of CXCL12-565 in Cxcr7-GFP+
interneurons that received CXCL12-565 alone or CXCL12-565/
AMD3100 (supplementary material Fig. S2Ba,c). Slices that received
CXCL12-565 and an excess of CXCL12 showed no CXCL12-565
signal, and slices that received CXCL12-565/CCX771 showed faint
CXCL12-565 signal, in Cxcr7-GFP+ interneurons (supplementary
material Fig. S2Bb,d). Collectively, our analyses of CXCL12-RFP
localization and CXCL12-565 uptake demonstrate that interneurons
efficiently internalize CXCL12 via CXCR7.
CXCR7 gauges CXCL12-induced CXCR4 activation in
telencephalic cultures
Next, we examined the influence of CXCR7 on CXCL12-induced
activation and downregulation of CXCR4 in telencephalic neurons
using immunoblots of E14.5 cultures. Blots were reacted with
the anti-CXCR4 antibody UMB-2 that recognizes the non-
phosphorylated C-terminal epitope 343-352, which undergoes
S346/347-phosphorylation upon CXCL12 stimulation (Mueller
et al., 2013). Thus, UMB-2 detects inactive CXCR4 in non-
dephosphorylated and total CXCR4 in dephosphorylated samples.
Consistently, lysate from cultures that received CXCL12 for 30 min
showed a strong signal difference between non-dephosphorylated
Fig. 3. CXCR7 regulates CXCL12-promoted activation and downregulation of CXCR4. (A,B) Immunoblots analyzing the expression level and activation
state of CXCR4 in lysates from E14.5 telencephalic neurons (Aa-e) and E15.5 Cxcr7−/− (X7−/−), Cxcl12−/− (XL12−/−) and Cxcl12−/−;Cxcr7−/− (XL12−/−;X7−/−)
brains (Ba-d). Blots were reacted with the anti-CXCR4 antibody UMB-2, which detects the non-phosphorylated C-terminus, and with anti-transferrin receptor
(TFR) to demonstrate equal loading. (Be) Lysates were split into two aliquots and purified with wheatgerm lectin agarose beads. Aliquots dephosphorylated
using Lambda protein phosphatase (λ-PP) show total CXCR4, whereas untreated aliquots show non-phosphorylated/inactive CXCR4 (ina.). (A) CXCL12
(XL12), AMD3100 (AMD), CCX771, and inactive compound (CCX704) were added for the indicated period. (Ab,c,e) For quantification of compound-induced
changes in CXCR4, the difference between the UMB-2/TFR signal ratios of compound-treated cultures (sample) and vehicle-treated sister cultures (vehicle)
was expressed as a percentage of UMB-2/TFR of the vehicle. Compound-treated and corresponding vehicle-treated groups were compared using one-way
ANOVA and Bonferroni’s post-test (*) or Student’s t-test (§) (three to ten independent repeats). (Ba-c) Immunoblots compare pooled lysates from two
knockouts with pooled lysates from two wild-type or heterozygous littermates (Ctrl). (Bd) Each CXCR4/TFR ratio was expressed as a percentage of the
CXCR4/TFR ratio of the corresponding λ-PP-treated control before repeats were averaged and analyzed using Student’s t-test. Data are mean+s.e.m.
*,§P≤0.05, **,§§P≤0.01 and ***P≤0.001; ns, not significant. (C) UMB-2 immunofluorescence in coronal head sections of a single E14.5 litter (genotypes as
specified in the figure). Higher magnifications (Ca0-d0) show the cerebral cortex. CPu, caudate putamen; GE, ganglionic eminence; latV, lateral ventricle; Ctx,
cortex. Scale bars: 200 µm.
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and dephosphorylated aliquots, which is characteristic of CXCR4
activation (Fig. 3Aa, lanes 3 and 4). Continuous CXCL12
treatment reduced the CXCR4 level (Fig. 3Aa, lanes 6 and 8;
Fig. 3Ac, 24 h XL12), indicating CXCL12-induced CXCR4
downregulation.
Cultures that were maintained over a 24-48 h period without
medium exchange exhibited considerable CXCR4 activation
(Fig. 3Aa, lanes 5 and 6). Activation was caused by endogenous
CXCL12, as 24 h treatment with CXCR4 antagonist (AMD3100)
rendered virtually all CXCR4 receptors inactive (Fig. 3Aa, lanes 9 and
10). Continuous antagonist treatment caused an increase in total
CXCR4 as compared with vehicle-treated control cultures (Fig. 3Ac,
48 hAMD3100), indicating prevention ofCXCL12-inducedCXCR4
downregulation. When CXCR7-mediated uptake of endogenous
CXCL12 was blocked by long-term CCX771 treatment, CXCR4
levels decreased (Fig. 3Aa, lanes 5, 11 and 6, 12; Fig. 3Ab,c, 24 h and
48 h CCX771). The CCX771 effect was blocked by AMD3100
(Fig. 3Ad, lanes 1, 3, 4; Fig. 3Ae),which suggests that itwasCXCL12
mediated. Collectively, these experiments provide evidence that
CXCR7 antagonism augments CXCL12-induced activation and
downregulation of CXCR4 in telencephalic cultures.
CXCR7 prevents excessive CXCR4 activation by CXCL12
We then assessed whether CXCR7 influences CXCL12-mediated
activation and downregulation of CXCR4 in the embryonic brain.We
analyzed Cxcr7−/−, Cxcl12−/− and Cxcl12−/−;Cxcr7−/− mice by
immunoblotting and immunofluorescence methods. Immunoblots
were reactedwithUMB-2 (Fig. 3B) and cortical sectionswithUMB-2
or the phosphorylation-insensitive anti-CXCR4 antibody 2B11
(Fig. 3C; supplementary material Fig. S3A). In all immunoblots,
the controls showed a marked difference between total and inactive
CXCR4 (Fig. 3Ba-c, lanes 1 and 2; Fig. 3Bd, total versus inactive
in control group), indicating substantial CXCR4 activation by
endogenous ligand. InCxcl12−/−mice, almost all CXCR4 receptors
were in the inactive state (Fig. 3Bb, lanes 3 and 4), suggesting that
CXCL12 is the only CXCR4-activating ligand in the embryonic
brain. Furthermore, CXCR4 signal was stronger in brain lysates
(Fig. 3Bb, lanes 2 and 4; Fig. 3Bd, control versus Cxcl12−/−) and
cortical sections (Fig. 3Ca,c) from these mutants. Given that the
level of Cxcr4 mRNA was apparently unaltered in Cxcl12
knockouts (Fig. 1Ca,b), these findings provide evidence that a
substantial proportion of CXCR4 in the embryonic brain becomes
downregulated after being activated by CXCL12.
Fig. 4. Scheme illustrating functions of CXCR4 and
CXCR7 in migrating cortical interneurons. (A) CXCL12
induces signaling and phosphorylation of CXCR4 as well
as internalization of the CXCL12/CXCR4 complex.
Internalized CXCR4 is recycled or degraded. CXCL12/
CXCR4 signaling supports interneuron migration in the MZ
and SVZ/IZ. Synthesis and degradation of CXCR4 are at
equilibrium. CXCR7 mediates rapid internalization and
degradation of CXCL12. (B) Absence of CXCR7 leads to
extracellular CXCL12 accumulation and excessive CXCR4
activation and degradation. Loss of CXCR4 results
in insufficient CXCL12/CXCR4 signaling and defective
interneuron migration. (C) Lack of CXCL12/CXCR4
signaling causes defective interneuron migration. (D) The
CXCR4 level is increased in the absence of CXCL12.
CXCR7 deficiency does not cause excessive CXCR4
degradation because CXCR4 does not become
phosphorylated when CXCL12 is not present. Lack of
CXCL12/CXCR4 signaling causes defective interneuron
migration.
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As reported previously (Sánchez-Alcañiz et al., 2011), CXCR4was
hardly detectable in brain lysates and cortical sections from Cxcr7−/−
mice (Fig. 3Ba, lanes2 and4;Fig. 3Bd, control groupversusCxcr7−/−;
Fig. 3Ca,b). We have now generated Cxcl12−/−;Cxcr7−/−mice to test
whether the lossofCXCR4 inCxcr7mutants ismediated byCXCL12,
and found that the activation state and expression level of CXCR4 in
Cxcl12−/−;Cxcr7−/− mice resembled those of Cxcl12−/− animals:
almost all CXCR4 receptorswere inactive (Fig. 3Bc, lanes 3 and4) and
the level of CXCR4 was increased compared with controls (Fig. 3Bc,
lanes 2 and 4; Fig. 3Bd, control group versus Cxcl12−/−;Cxcr7−/−).
CXCR4 immunostaining in the cortex was indistinguishable
between Cxcl12−/−;Cxcr7−/− and Cxcl12−/− mice: both cohorts
showed a similar increase in CXCR4 signal as compared with the
control (Fig. 3Ca,c,d) and a similar layering defect of CXCR4-
immunoreactive neurons (supplementary material Fig. S3B).
Our findings in Cxcr7−/− and Cxcl12−/−;Cxcr7−/− animals
demonstrate that the embryonic brain contains sufficient CXCL12 to
induce near complete CXCR4 degradation unless CXCR7-dependent
scavenger activity prevents excessive CXCR4 activation byCXCL12.
These findings and conclusions are summarized in Fig. 4.
MATERIALS AND METHODS
Animals and histochemistry
Animal procedures were in accordance with German and EU guidelines.
Established mouse lines, in situ hybridization and immunohistochemical
procedures, probes and antibodies were used (Memi et al., 2013; Stumm
et al., 2002, 2003; Sánchez-Alcañiz et al., 2011). Transcripts from the
Neomycin resistance cassette of Cxcr4 mutants (Zou et al., 1998) were
detected with a Neo probe cloned by PCR using Cxcr4+/− genomic
DNA and 50-ATGGGATCGGCCATTGAAC-30 and 50-TCAGAAG-
AACTCGTCAAG-30 primers.
CXCL12-565 uptake
Recombinant Atto565-tagged CXCL12 (CXCL12-565) (Yang et al., 1999)
was labeled with a C-terminal ybbR13 tag (George et al., 2004; Zhou et al.,
2007). Human embryonic kidney (HEK293) cells were transiently
transfected as described (Hoffmann et al., 2012). Surface CXCR4 and
CXCR7 receptors were immunostained in fixed non-permeabilized cells
with N-terminal antibodies 2B11 (BD Biosciences) and 11G8 (Zabel et al.,
2009), respectively. HEK293 cells and cortical slices were incubated with
20 nM CXCL12-565 at 37°C, washed, and fixed before confocal imaging.
Immunoblotting
Neuronal cultures (25×106 cells/dish) were prepared from E14.5
telencephalic vesicles and grown in Neurobasal medium/B27 supplement
(Invitrogen). Compounds (20 nM CXCL12, Peprotech; 6 µM AMD3100,
Sigma; 1 µM CCX771/CCX704, ChemoCentryx) were added 4 h after
seeding in 6 ml fresh medium. Immunoblotting, detection and analysis were
as described (Sánchez-Alcañiz et al., 2011).
Live cell imaging
Coronal brain slices (300 µm) were cut on a Vibratome (Leica), placed in
35 mm glass-bottom dishes (MatTek) and embedded in collagen (3 mg/ml,
BD Biosciences). After adding DMEM lacking Phenol Red (Gibco), slices
were transferred to the 37°C/5% CO2 tissue incubation chamber attached to
an LSM510 Meta inverted confocal microscope (Zeiss). The following live
cell acquisition setup was used: EC Plan-Neofluor 20×/0.50 M27 objective,
time series (interval: 10 min), z-stack acquisition, maximum intensity
projection processing using Zen software (Zeiss). Statistical tests are
specified in the figure legends (one, two and three symbols indicate P≤0.05,
P≤0.01, and P≤0.001, respectively).
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